Full Press Release Details
RESULTS OF ANNUAL GENERAL MEETING
Company wishes to advise that all resolutions contained in the Notice of Meeting were carried by poll.
accordance with ASX Listing rule 3.13.2 and Section 251AA(1) of the Corporations Act 2001, the following page provides
information in relation to the proxy votes received for each resolution considered by Members of the Company at the Annual General
Chairman voted undirected proxies in his control in favour of all resolutions.
1,8 and 9 are resolutions that required 75% approval to be passed. This threshold has been achieved and these resolutions passed.
Therapeutics Limited
THERAPEUTICS LIMITED
2020 Annual General Meeting
Wednesday, 18 November 2020
following information is provided in accordance with section 251AA(2) of the Corporations Act 2001 (Cth) and ASX Listing Rule
| Resolution details | Instructions given to validly appointed proxies (as at proxy close) | Number of votes cast on the poll (where applicable) | Resolution Result | |||||||||||||||
| Resolution | Resolution Type | For | Against | Proxy's Discretion | Abstain | For | Against | Abstain* | Carried / Not Carried | |||||||||
| Resolution 1 Non-binding resolution to adopt Remuneration Report | Ordinary | 315,711,326 95.56% | 9,937,610 3.01% | 4,750,186 1.43% | 1,491,519 | 320,461,512 96.99% | 9,937,610 3.01% | 1,491,519 | Carried | |||||||||
| Resolution 2 Re-Election of Director - Mr Peter Marks | Ordinary | 328,101,326 94.56% | 14,126,458 4.07% | 4,750,186 1.37% | 2,047,576 | 332,851,512 95.93% | 14,126,458 4.07% | 2,047,576 | Carried | |||||||||
| Resolution 3 Re-Election of Director - Mr Lawrence Gozlan | Ordinary | 327,812,822 94.47% | 14,369,638 4.14% | 4,795,186 1.39% | 2,047,900 | 332,608,008 95.86% | 14,369,638 4.14% | 2,047,900 | Carried | |||||||||
| Resolution 4 Approval to refresh and amend 2004 ASX Plan | Ordinary | 314,850,243 95.33% | 10,602,641 3.21% | 4,845,086 1.46% | 1,592,572 | 319,695,329 96.79% | 10,602,641 3.21% | 1,592,572 | Carried | |||||||||
| Resolution 5 Approval to refresh and amend 2018 ADS Plan | Ordinary | 315,582,587 95.52% | 10,039,236 3.04% | 4,751,688 1.44% | 1,517,032 | 320,334,275 96.96% | 10,039,236 3.04% | 1,517,032 | Carried | |||||||||
| Resolution 6 Ratification of prior issue of shares | Ordinary | 330,079,772 95.15% | 12,094,124 3.48% | 4,750,188 1.37% | 2,010,679 | 334,829,960 96.51% | 12,094,124 3.49% | 2,010,679 | Carried | |||||||||
| Resolution 7 Approval for issue of securities | Ordinary | 323,146,414 92.86% | 20,083,404 5.77% | 4,750,186 1.36% | 1,055,537 | 327,896,600 94.23% | 20,083,404 5.77% | 1,055,537 | Carried | |||||||||
| Resolution 8 Amendment to Company constitution | Special | 330,873,819 95.54% | 10,672,653 3.08% | 4,762,186 1.38% | 2,716,885 | 335,636,005 96.92% | 10,672,653 3.08% | 2,716,885 | Carried | |||||||||
| Resolution 9 Approval of 10% Placement issue | Special | 330,287,704 95.05% | 12,705,141 3.65% | 4,511,756 1.30% | 1,521,040 | 334,799,460 96.34% | 12,705,141 3.66% | 1,521,040 | Carried |